Drug class in one race
DPP-4 drugs for Type 2 Diabetes
20 tracked DPP-4 drugs in the Type 2 Diabetes race. The class explanation lives on the DPP-4 page; the full indication pipeline across every mechanism is on the Type 2 Diabetes page.
4 approved / phase 414 Phase 31 Phase 11 preclinical / unstaged
Head-to-head evidence: Alogliptin vs Anagliptin · Alogliptin vs Cofrogliptin · Alogliptin vs DBPR108 · Alogliptin vs Evogliptin · Alogliptin vs Gemigliptin · Alogliptin vs Gosogliptin